FDA Licenses First At-Home Administered Influenza Vaccine
by Carolyn Hendler, JD
The U.S. Food and Drug Administration (FDA) has licensed the first of its kind live attenuated nasal spray influenza vaccine that can ...
Pharma Developing Bird Flu Vaccine for Humans As Animals Get Sick
by Rishma Parpia
Pharmaceutical companies GSK (formerly known as GlaxoSmithKline), Moderna and CSL Seqirus announced that they are developing and ready to test ...
Group B Strep Vaccine for Pregnant Women on Fast Track for FDA Approval
by Natasha Hobley
Pfizer is conducting phase 2 trials for the development of a vaccine that will target pregnant women to prevent newborns ...
Moderna, Novavax Developing Combined Single-Dose COVID-19 and Influenza Vaccine
by Rishma Parpia
American pharmaceutical and biotechnology company Moderna, Inc., which partnered with the U.S. National Institutes of Allergy and Infectious Diseases (NIAID) ...
Another Shot at a Vaccine for Lyme Disease
by Carolyn Hendler, JD
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to ...
Public Acceptance of COVID-19 Vaccine Faces Many Hurdles
by Kate Raines
Story Highlights Even before a vaccine against COVID-19 has been introduced to the public in the U.S., expectations for it ...
Intranasal COVID-19 Vaccine May Be More Effective Than Injected Vaccines
by Rishma Parpia
There are more than 150 experimental COVID-19 vaccines under development around the world, all of which are being designed for ...
Children Recruited in U.K. for COVID-19 Vaccine Trial
by TVR Staff
The University of Oxford’s Jenner Institute and Oxford Vaccine Group in the United Kingdom has announced that its researchers have ...
COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually
by Marco Cáceres
In an interview with the JAMA on June 2, 2020, Anthony Fauci, MD, director of the U.S. National Institute of Allergy ...
In this section
Latest
Popular
Comments
Latest
The PREP Act’s Role in Shielding Big Pharma and Incentivizing Harmful COVID-19 Treatments
by Megan Redshaw | Guest Writer
Popular
Comments
malinda Barker on FDA Licenses First At-Home Administered Influenza Vaccine
K on Kindergarten Vaccination Rates Decrease as Vaccine Exemptions Increase
John Riesenman on The PREP Act’s Role in Shielding Big Pharma and Incentivizing Harmful COVID-19 Treatments
Mary Ann ISAAC on The PREP Act’s Role in Shielding Big Pharma and Incentivizing Harmful COVID-19 Treatments
Richard on FDA Licenses First At-Home Administered Influenza Vaccine
